Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and atrial natriuretic factor

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with atrial natriuretic factor in 1 studies

Compound Research Comparison

Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Recent Studies (post-2010)
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Studies
(atrial natriuretic factor)
Trials
(atrial natriuretic factor)
Recent Studies (post-2010) (atrial natriuretic factor)
21455815,4551,1051,760

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, GY; Kim, SH; Kim, SZ; Park, WH; Yuan, K1

Other Studies

1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and atrial natriuretic factor

ArticleYear
Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII.
    Peptides, 2008, Volume: 29, Issue:12

    Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Atrial Natriuretic Factor; Calcium; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP; Extracellular Fluid; Heart Atria; In Vitro Techniques; Inositol 1,4,5-Trisphosphate Receptors; Male; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; Ryanodine Receptor Calcium Release Channel; Type C Phospholipases

2008